|
Volumn 32, Issue 4, 2001, Pages 546-551
|
Low infectious morbidity after intensive chemotherapy and autologous peripheral blood progenitor cell transplantation in the outpatient setting for women with breast cancer
a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CARMUSTINE;
CISPLATIN;
CYCLOPHOSPHAMIDE;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
ADULT;
AGED;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CANCER PATIENT;
DRUG EFFECT;
FEMALE;
FOLLOW UP;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HIGH RISK POPULATION;
HOSPITAL ADMISSION;
HOSPITALIZATION;
HUMAN;
INFECTIOUS COMPLICATION;
MAJOR CLINICAL STUDY;
MUCOSA INFLAMMATION;
PRIORITY JOURNAL;
PROPHYLAXIS;
STEM CELL;
ADULT;
AGED;
AMBULATORY CARE;
AMBULATORY CARE FACILITIES;
ANTI-INFECTIVE AGENTS;
ANTIBIOTIC PROPHYLAXIS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CARMUSTINE;
CISPLATIN;
COMBINED MODALITY THERAPY;
CYCLOPHOSPHAMIDE;
FEMALE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
INFECTION;
MIDDLE AGED;
MORBIDITY;
TRANSPLANTATION, AUTOLOGOUS;
|
EID: 0035864523
PISSN: 10584838
EISSN: None
Source Type: Journal
DOI: 10.1086/318715 Document Type: Article |
Times cited : (14)
|
References (25)
|